United Nations General Assembly Adopts Resolution Calling For Holistic COVID-19 Response; United States & Israel Vote Against The Bloc 14/09/2020 Grace Ren The United Nations General Assembly adopted an omnibus resolution urging Member States to mount a coordinated global coronavirus response on 11 September. The resolution (Document A/74/L.92), submitted by the President of the Assembly Tijjani Muhammad-Bande, was almost passed unanimously, with only two countries voting against and two abstaining. United States & Israel Vote Against the […] Continue reading -> COVID-19’s ‘Slow Burn’ – Africa’s Low Death Rate Puzzles Researchers 14/09/2020 Kerry Cullinan Cape Town, South Africa – Dire predictions of Africa being overwhelmed by a tsunami of COVID-19 infections and deaths have not materialized – yet – and this is confounding many researchers. So whether the reason is the continent’s youthful population, a certain level of “herd immunity” gained from prior exposure to other coronaviruses, or simply […] Continue reading -> COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> In COVID-19 Battle, Africa Needs To “Own” Its Public Health Space – Senior Africa CDC Official 10/09/2020 Paul Adepoju Ibadan, Nigeria – The pandemic has brought to the fore Africa’s reliance on international support for its health sector – and it is also challenging the continent’s ability to build up its resilience when donors fall through. “There is a new public health order that is coming because of COVID-19. COVID-19 has opened our eyes […] Continue reading -> Stigma Blots Kenya’s COVID-19 War – Some Patients Fearful Of Seeking Treatment 08/09/2020 Maina Waruru Nairobi, Kenya – While banker Peter Karagu is one of the over 35,000 people who have contracted COVID-19 disease in Kenya over the past 6 months, he cannot in any way be described as an ordinary victim of the respiratory illness. Throughout his 22 days confined at an isolation ward at Kenyatta University Teaching Research […] Continue reading -> Countries Are Falling Behind In Tackling Non-Communicable Diseases, But 2030 Targets Are Still Within Reach 04/09/2020 Grace Ren Most countries in the world are not on track to reduce premature deaths from non-communicable diseases (NCD) by a third by 2030, according to a new NCD 2030 Countdown report published by The Lancet. “An estimated 150 million people will lose their lives too early from a noncommunicable disease over the next decade and right […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding 03/09/2020 Grace Ren The US Biomedical Advanced Research and Development Agency (BARDA) is investigating Moderna’s patents for allegedly failing to disclose federal funding, making it the second US agency to review the company’s patents. The BARDA probe comes just days after the US Defense Advanced Research Projects Agency (DARPA) began an investigation into Moderna’s patents, after pharma watchdog […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19’s ‘Slow Burn’ – Africa’s Low Death Rate Puzzles Researchers 14/09/2020 Kerry Cullinan Cape Town, South Africa – Dire predictions of Africa being overwhelmed by a tsunami of COVID-19 infections and deaths have not materialized – yet – and this is confounding many researchers. So whether the reason is the continent’s youthful population, a certain level of “herd immunity” gained from prior exposure to other coronaviruses, or simply […] Continue reading -> COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> In COVID-19 Battle, Africa Needs To “Own” Its Public Health Space – Senior Africa CDC Official 10/09/2020 Paul Adepoju Ibadan, Nigeria – The pandemic has brought to the fore Africa’s reliance on international support for its health sector – and it is also challenging the continent’s ability to build up its resilience when donors fall through. “There is a new public health order that is coming because of COVID-19. COVID-19 has opened our eyes […] Continue reading -> Stigma Blots Kenya’s COVID-19 War – Some Patients Fearful Of Seeking Treatment 08/09/2020 Maina Waruru Nairobi, Kenya – While banker Peter Karagu is one of the over 35,000 people who have contracted COVID-19 disease in Kenya over the past 6 months, he cannot in any way be described as an ordinary victim of the respiratory illness. Throughout his 22 days confined at an isolation ward at Kenyatta University Teaching Research […] Continue reading -> Countries Are Falling Behind In Tackling Non-Communicable Diseases, But 2030 Targets Are Still Within Reach 04/09/2020 Grace Ren Most countries in the world are not on track to reduce premature deaths from non-communicable diseases (NCD) by a third by 2030, according to a new NCD 2030 Countdown report published by The Lancet. “An estimated 150 million people will lose their lives too early from a noncommunicable disease over the next decade and right […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding 03/09/2020 Grace Ren The US Biomedical Advanced Research and Development Agency (BARDA) is investigating Moderna’s patents for allegedly failing to disclose federal funding, making it the second US agency to review the company’s patents. The BARDA probe comes just days after the US Defense Advanced Research Projects Agency (DARPA) began an investigation into Moderna’s patents, after pharma watchdog […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 May Change How Vaccines Are Sold & Distributed – But Can New Systems Really Achieve Global Access? 11/09/2020 Grace Ren COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading -> In COVID-19 Battle, Africa Needs To “Own” Its Public Health Space – Senior Africa CDC Official 10/09/2020 Paul Adepoju Ibadan, Nigeria – The pandemic has brought to the fore Africa’s reliance on international support for its health sector – and it is also challenging the continent’s ability to build up its resilience when donors fall through. “There is a new public health order that is coming because of COVID-19. COVID-19 has opened our eyes […] Continue reading -> Stigma Blots Kenya’s COVID-19 War – Some Patients Fearful Of Seeking Treatment 08/09/2020 Maina Waruru Nairobi, Kenya – While banker Peter Karagu is one of the over 35,000 people who have contracted COVID-19 disease in Kenya over the past 6 months, he cannot in any way be described as an ordinary victim of the respiratory illness. Throughout his 22 days confined at an isolation ward at Kenyatta University Teaching Research […] Continue reading -> Countries Are Falling Behind In Tackling Non-Communicable Diseases, But 2030 Targets Are Still Within Reach 04/09/2020 Grace Ren Most countries in the world are not on track to reduce premature deaths from non-communicable diseases (NCD) by a third by 2030, according to a new NCD 2030 Countdown report published by The Lancet. “An estimated 150 million people will lose their lives too early from a noncommunicable disease over the next decade and right […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding 03/09/2020 Grace Ren The US Biomedical Advanced Research and Development Agency (BARDA) is investigating Moderna’s patents for allegedly failing to disclose federal funding, making it the second US agency to review the company’s patents. The BARDA probe comes just days after the US Defense Advanced Research Projects Agency (DARPA) began an investigation into Moderna’s patents, after pharma watchdog […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
In COVID-19 Battle, Africa Needs To “Own” Its Public Health Space – Senior Africa CDC Official 10/09/2020 Paul Adepoju Ibadan, Nigeria – The pandemic has brought to the fore Africa’s reliance on international support for its health sector – and it is also challenging the continent’s ability to build up its resilience when donors fall through. “There is a new public health order that is coming because of COVID-19. COVID-19 has opened our eyes […] Continue reading -> Stigma Blots Kenya’s COVID-19 War – Some Patients Fearful Of Seeking Treatment 08/09/2020 Maina Waruru Nairobi, Kenya – While banker Peter Karagu is one of the over 35,000 people who have contracted COVID-19 disease in Kenya over the past 6 months, he cannot in any way be described as an ordinary victim of the respiratory illness. Throughout his 22 days confined at an isolation ward at Kenyatta University Teaching Research […] Continue reading -> Countries Are Falling Behind In Tackling Non-Communicable Diseases, But 2030 Targets Are Still Within Reach 04/09/2020 Grace Ren Most countries in the world are not on track to reduce premature deaths from non-communicable diseases (NCD) by a third by 2030, according to a new NCD 2030 Countdown report published by The Lancet. “An estimated 150 million people will lose their lives too early from a noncommunicable disease over the next decade and right […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding 03/09/2020 Grace Ren The US Biomedical Advanced Research and Development Agency (BARDA) is investigating Moderna’s patents for allegedly failing to disclose federal funding, making it the second US agency to review the company’s patents. The BARDA probe comes just days after the US Defense Advanced Research Projects Agency (DARPA) began an investigation into Moderna’s patents, after pharma watchdog […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Stigma Blots Kenya’s COVID-19 War – Some Patients Fearful Of Seeking Treatment 08/09/2020 Maina Waruru Nairobi, Kenya – While banker Peter Karagu is one of the over 35,000 people who have contracted COVID-19 disease in Kenya over the past 6 months, he cannot in any way be described as an ordinary victim of the respiratory illness. Throughout his 22 days confined at an isolation ward at Kenyatta University Teaching Research […] Continue reading -> Countries Are Falling Behind In Tackling Non-Communicable Diseases, But 2030 Targets Are Still Within Reach 04/09/2020 Grace Ren Most countries in the world are not on track to reduce premature deaths from non-communicable diseases (NCD) by a third by 2030, according to a new NCD 2030 Countdown report published by The Lancet. “An estimated 150 million people will lose their lives too early from a noncommunicable disease over the next decade and right […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding 03/09/2020 Grace Ren The US Biomedical Advanced Research and Development Agency (BARDA) is investigating Moderna’s patents for allegedly failing to disclose federal funding, making it the second US agency to review the company’s patents. The BARDA probe comes just days after the US Defense Advanced Research Projects Agency (DARPA) began an investigation into Moderna’s patents, after pharma watchdog […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Countries Are Falling Behind In Tackling Non-Communicable Diseases, But 2030 Targets Are Still Within Reach 04/09/2020 Grace Ren Most countries in the world are not on track to reduce premature deaths from non-communicable diseases (NCD) by a third by 2030, according to a new NCD 2030 Countdown report published by The Lancet. “An estimated 150 million people will lose their lives too early from a noncommunicable disease over the next decade and right […] Continue reading -> Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding 03/09/2020 Grace Ren The US Biomedical Advanced Research and Development Agency (BARDA) is investigating Moderna’s patents for allegedly failing to disclose federal funding, making it the second US agency to review the company’s patents. The BARDA probe comes just days after the US Defense Advanced Research Projects Agency (DARPA) began an investigation into Moderna’s patents, after pharma watchdog […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gilead Says Remdesivir Shortages Due To Supply Chain Issues, Civil Society Argues For Wider Licensing 03/09/2020 Svĕt Lustig Vijay As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading -> US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding 03/09/2020 Grace Ren The US Biomedical Advanced Research and Development Agency (BARDA) is investigating Moderna’s patents for allegedly failing to disclose federal funding, making it the second US agency to review the company’s patents. The BARDA probe comes just days after the US Defense Advanced Research Projects Agency (DARPA) began an investigation into Moderna’s patents, after pharma watchdog […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US Biomedical Advanced Research & Development Agency Reviews Moderna’s US Patents For Alleged Failure To Disclose Federal Funding 03/09/2020 Grace Ren The US Biomedical Advanced Research and Development Agency (BARDA) is investigating Moderna’s patents for allegedly failing to disclose federal funding, making it the second US agency to review the company’s patents. The BARDA probe comes just days after the US Defense Advanced Research Projects Agency (DARPA) began an investigation into Moderna’s patents, after pharma watchdog […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> Posts navigation Older postsNewer posts